Extreme CD8 T Cell Requirements for Anti-Malarial Liver-Stage Immunity following Immunization with Radiation Attenuated Sporozoites
Radiation-attenuated Plasmodium sporozoites (RAS) are the only vaccine shown to induce sterilizing protection against malaria in both humans and rodents. Importantly, these “whole-parasite” vaccines are currently under evaluation in human clinical trials. Studies with inbred mice reveal that RAS-induced CD8 T cells targeting liver-stage parasites are critical for protection. However, the paucity of defined T cell epitopes for these parasites has precluded precise understanding of the specific characteristics of RAS-induced protective CD8 T cell responses. Thus, it is not known whether quantitative or qualitative differences in RAS-induced CD8 T cell responses underlie the relative resistance or susceptibility of immune inbred mice to sporozoite challenge. Moreover, whether extraordinarily large CD8 T cell responses are generated and required for protection following RAS immunization, as has been described for CD8 T cell responses following single-antigen subunit vaccination, remains unknown. Here, we used surrogate T cell activation markers to identify and track whole-parasite, RAS-vaccine-induced effector and memory CD8 T cell responses. Our data show that the differential susceptibility of RAS-immune inbred mouse strains to Plasmodium berghei or P. yoelii sporozoite challenge does not result from host- or parasite-specific decreases in the CD8 T cell response. Moreover, the surrogate activation marker approach allowed us for the first time to evaluate CD8 T cell responses and protective immunity following RAS-immunization in outbred hosts. Importantly, we show that compared to a protective subunit vaccine that elicits a CD8 T cell response to a single epitope, diversifying the targeted antigens through whole-parasite RAS immunization only minimally, if at all, reduced the numerical requirements for memory CD8 T cell-mediated protection. Thus, our studies reveal that extremely high frequencies of RAS-induced memory CD8 T cells are required, but may not suffice, for sterilizing anti-Plasmodial immunity. These data provide new insights into protective CD8 T cell responses elicited by RAS-immunization in genetically diverse hosts, information with relevance to developing attenuated whole-parasite vaccines.
Vyšlo v časopise:
Extreme CD8 T Cell Requirements for Anti-Malarial Liver-Stage Immunity following Immunization with Radiation Attenuated Sporozoites. PLoS Pathog 6(7): e32767. doi:10.1371/journal.ppat.1000998
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1000998
Souhrn
Radiation-attenuated Plasmodium sporozoites (RAS) are the only vaccine shown to induce sterilizing protection against malaria in both humans and rodents. Importantly, these “whole-parasite” vaccines are currently under evaluation in human clinical trials. Studies with inbred mice reveal that RAS-induced CD8 T cells targeting liver-stage parasites are critical for protection. However, the paucity of defined T cell epitopes for these parasites has precluded precise understanding of the specific characteristics of RAS-induced protective CD8 T cell responses. Thus, it is not known whether quantitative or qualitative differences in RAS-induced CD8 T cell responses underlie the relative resistance or susceptibility of immune inbred mice to sporozoite challenge. Moreover, whether extraordinarily large CD8 T cell responses are generated and required for protection following RAS immunization, as has been described for CD8 T cell responses following single-antigen subunit vaccination, remains unknown. Here, we used surrogate T cell activation markers to identify and track whole-parasite, RAS-vaccine-induced effector and memory CD8 T cell responses. Our data show that the differential susceptibility of RAS-immune inbred mouse strains to Plasmodium berghei or P. yoelii sporozoite challenge does not result from host- or parasite-specific decreases in the CD8 T cell response. Moreover, the surrogate activation marker approach allowed us for the first time to evaluate CD8 T cell responses and protective immunity following RAS-immunization in outbred hosts. Importantly, we show that compared to a protective subunit vaccine that elicits a CD8 T cell response to a single epitope, diversifying the targeted antigens through whole-parasite RAS immunization only minimally, if at all, reduced the numerical requirements for memory CD8 T cell-mediated protection. Thus, our studies reveal that extremely high frequencies of RAS-induced memory CD8 T cells are required, but may not suffice, for sterilizing anti-Plasmodial immunity. These data provide new insights into protective CD8 T cell responses elicited by RAS-immunization in genetically diverse hosts, information with relevance to developing attenuated whole-parasite vaccines.
Zdroje
1. BryceJ
Boschi-PintoC
ShibuyaK
BlackRE
2005
WHO estimates of the causes of death in children.
Lancet
365
1147
1152
2. HaySI
SnowRW
2006
The Malaria Atlas Project: Developing Global Maps of Malaria Risk.
PLoS Med
3
e473
3. SachsJ
MalaneyP
2002
The economic and social burden of malaria.
Nature
415
680
685
4. SnowRW
GuerraCA
NoorAM
MyintHY
HaySI
2005
The global distribution of clinical episodes of Plasmodium falciparum malaria.
Nature
434
214
217
5. GuerraCA
SnowRW
HaySI
2006
Mapping the global extent of malaria in 2005.
Trends Parasitol
22
353
358
6. TodrykSM
HillAV
2007
Malaria vaccines: the stage we are at.
Nat Rev Microbiol
5
487
489
7. ClydeDF
1975
Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites.
Am J Trop Med Hyg
24
397
401
8. HoffmanSL
GohLM
LukeTC
SchneiderI
LeTP
2002
Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites.
J Infect Dis
185
1155
1164
9. NussenzweigRS
VanderbergJ
MostH
OrtonC
1967
Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei.
Nature
216
160
162
10. ButlerD
2009
Initiative targets malaria eradication.
Nature
462
19
11. DoolanDL
HoffmanSL
2000
The complexity of protective immunity against liver-stage malaria.
J Immunol
165
1453
1462
12. WeissWR
BerzofskyJA
HoughtenRA
SedegahM
HollindaleM
1992
A T cell clone directed at the circumsporozoite protein which protects mice against both Plasmodium yoelii and Plasmodium berghei.
J Immunol
149
2103
2109
13. RomeroP
MaryanskiJL
CorradinG
NussenzweigRS
NussenzweigV
1989
Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria.
Nature
341
323
326
14. GrunerAC
MauduitM
TewariR
RomeroJF
DepinayN
2007
Sterile protection against malaria is independent of immune responses to the circumsporozoite protein.
PLoS One
2
e1371
15. KumarKA
SanoG
BoscardinS
NussenzweigRS
NussenzweigMC
2006
The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites.
Nature
444
937
940
16. SchmidtNW
PodyminoginRL
ButlerNS
BadovinacVP
TuckerBJ
2008
Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria.
Proc Natl Acad Sci U S A
105
14017
14022
17. MillerJD
van der MostRG
AkondyRS
GlidewellJT
AlbottS
2008
Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines.
Immunity
28
710
722
18. RaiD
PhamNL
HartyJT
BadovinacVP
2009
Tracking the Total CD8 T Cell Response to Infection Reveals Substantial Discordance in Magnitude and Kinetics between Inbred and Outbred Hosts.
J Immunol
183
7672
7681
19. RieckmannKH
1990
Human immunization with attenuated sporozoites.
Bull World Health Organ
68
Suppl
13
16
20. WeissWR
GoodMF
HollingdaleMR
MillerLH
BerzofskyJA
1989
Genetic control of immunity to Plasmodium yoelii sporozoites.
J Immunol
143
4263
4266
21. KaechSM
HembyS
KershE
AhmedR
2002
Molecular and functional profiling of memory CD8 T cell differentiation.
Cell
111
837
851
22. BuschDH
PilipIM
VijhS
PamerEG
1998
Coordinate regulation of complex T cell populations responding to bacterial infection.
Immunity
8
353
362
23. VanderbergJP
NussenzweigRS
MostH
1968
Further studies on the Plasmodium berghei-Anopheles stephensi–rodent system of mammalian malaria.
J Parasitol
54
1009
1016
24. ZechiniB
CordierL
NgonseuE
D'AlessandroU
WeryM
1999
Plasmodium berghei development in irradiated sporozoite-immunized C57BL6 mice.
Parasitology
118 ( Pt 4)
335
338
25. SchellerLF
AzadAF
1995
Maintenance of protective immunity against malaria by persistent hepatic parasites derived from irradiated sporozoites.
Proc Natl Acad Sci U S A
92
4066
4068
26. BerenzonD
SchwenkRJ
LetellierL
Guebre-XabierM
WilliamsJ
2003
Protracted protection to Plasmodium berghei malaria is linked to functionally and phenotypically heterogeneous liver memory CD8+ T cells.
J Immunol
171
2024
2034
27. NussenzweigR
VanderbergJ
MostH
1969
Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. IV. Dose response, specificity and humoral immunity.
Mil Med
134
1176
1182
28. NussenzweigRS
VanderbergJP
MostH
OrtonC
1969
Specificity of protective immunity produced by x-irradiated Plasmodium berghei sporozoites.
Nature
222
488
489
29. OliveiraGA
KumarKA
Calvo-CalleJM
OthoroC
AltszulerD
2008
Class II-restricted protective immunity induced by malaria sporozoites.
Infect Immun
76
1200
1206
30. DoolanDL
HoffmanSL
1999
IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model.
J Immunol
163
884
892
31. LabaiedM
HarupaA
DumpitRF
CoppensI
MikolajczakSA
2007
Plasmodium yoelii sporozoites with simultaneous deletion of P52 and P36 are completely attenuated and confer sterile immunity against infection.
Infect Immun
75
3758
3768
32. SedegahM
WeissWW
HoffmanSL
2007
Cross-protection between attenuated Plasmodium berghei and P. yoelii sporozoites.
Parasite Immunol
29
559
565
33. TarunAS
DumpitRF
CamargoN
LabaiedM
LiuP
2007
Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.
J Infect Dis
196
608
616
34. KhanZM
VanderbergJP
1992
Specific inflammatory cell infiltration of hepatic schizonts in BALB/c mice immunized with attenuated Plasmodium yoelii sporozoites.
Int Immunol
4
711
718
35. KumarKA
BaxterP
TarunAS
KappeSH
NussenzweigV
2009
Conserved protective mechanisms in radiation and genetically attenuated uis3(-) and uis4(-) Plasmodium sporozoites.
PLoS One
4
e4480
36. ChattopadhyayR
ContehS
LiM
JamesER
EpsteinJE
2009
The Effects of radiation on the safety and protective efficacy of an attenuated Plasmodium yoelii sporozoite malaria vaccine.
Vaccine
27
3675
3680
37. TrimnellA
TakagiA
GuptaM
RichieTL
KappeSH
2009
Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes.
J Immunol
183
5870
5878
38. SchofieldL
VillaquiranJ
FerreiraA
SchellekensH
NussenzweigR
1987
Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites.
Nature
330
664
666
39. WherryEJ
TeichgraberV
BeckerTC
MasopustD
KaechSM
2003
Lineage relationship and protective immunity of memory CD8 T cell subsets.
Nat Immunol
4
225
234
40. TomiyamaH
TakataH
MatsudaT
TakiguchiM
2004
Phenotypic classification of human CD8+ T cells reflecting their function: inverse correlation between quantitative expression of CD27 and cytotoxic effector function.
Eur J Immunol
34
999
1010
41. KuCC
MurakamiM
SakamotoA
KapplerJ
MarrackP
2000
Control of homeostasis of CD8+ memory T cells by opposing cytokines.
Science
288
675
678
42. SchmidtNW
ButlerNS
HartyJT
2009
CD8 T cell immunity to Plasmodium permits generation of protective antibodies after repeated sporozoite challenge.
Vaccine
27
6103
6106
43. BrionesMR
TsujiM
NussenzweigV
1996
The large difference in infectivity for mice of Plasmodium berghei and Plasmodium yoelii sporozoites cannot be correlated with their ability to enter into hepatocytes.
Mol Biochem Parasitol
77
7
17
44. CockburnIA
ChenYC
OverstreetMG
LeesJR
van RooijenN
2010
Prolonged antigen presentation is required for optimal CD8+ T cell responses against malaria liver stage parasites.
PLoS Pathog
6
e1000877
45. JobeO
LumsdenJ
MuellerAK
WilliamsJ
Silva-RiveraH
2007
Genetically attenuated Plasmodium berghei liver stages induce sterile protracted protection that is mediated by major histocompatibility complex Class I-dependent interferon-gamma-producing CD8+ T cells.
J Infect Dis
196
599
607
46. AlyAS
MikolajczakSA
RiveraHS
CamargoN
Jacobs-LorenaV
2008
Targeted deletion of SAP1 abolishes the expression of infectivity factors necessary for successful malaria parasite liver infection.
Mol Microbiol
69
152
163
47. VaughanAM
O'NeillMT
TarunAS
CamargoN
PhuongTM
2009
Type II fatty acid synthesis is essential only for malaria parasite late liver stage development.
Cell Microbiol
11
506
520
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 7
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- RNA Virus Replication Complexes
- Virus-Infection or 5′ppp-RNA Activates Antiviral Signal through Redistribution of IPS-1 Mediated by MFN1
- Functional Genetic Diversity among Complex Clinical Isolates: Delineation of Conserved Core and Lineage-Specific Transcriptomes during Intracellular Survival
- Extreme CD8 T Cell Requirements for Anti-Malarial Liver-Stage Immunity following Immunization with Radiation Attenuated Sporozoites